日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Associate toxin-antitoxin with CRISPR-Cas to harness (ATTACH) engineered microbes

将毒素-抗毒素与 CRISPR-Cas 结合以利用(ATTACH)工程微生物

Zhao, Huiwei; Zhou, Tao; Zhang, Ming; Wang, Chengqiang; Wang, Rui; Shu, Xian; Cheng, Feiyue; Xue, Qiong; Liu, Chao; Xu, Jing; Cao, Xinyue; Du, Jun; Wang, Liangliang; Liu, Hongwei; Li, Ming

Integrative Genomic Profiling of Pediatric Solid Tumors Reveals Clinically Relevant Variants and Chromosomal Arm Aneuploidies Signatures

儿童实体瘤的整合基因组分析揭示了具有临床意义的变异和染色体臂非整倍体特征

Yan, Bingxiao; Wang, Jinhu; Xiong, Jieni; Liu, Shuangai; Tang, Yinbing; He, Ziqi; Yan, Hujin; Guo, Bize; Chen, Chen; Zhang, Yijie; Zhu, Qinfang; Cai, Jiabin; He, Min; Wu, Xuan; Mao, Junqing; Zhang, Lifeng; Gu, Weizhong; Zhu, Zhu; Li, Zheming; Xiao, Rui; Shu, Qiang; Yu, Gang; Tao, Ting

12/15-lipoxygenase mediates disturbed flow-induced endothelial dysfunction and atherosclerosis

12/15-脂氧合酶介导紊乱血流诱导的内皮功能障碍和动脉粥样硬化

Chen, Jia Wei; Chen, Shi Li; Wu, Xin Rui; Shu, Xin Yi; Tang, Si Yi; Yuan, He; Li, You Ran; Quan, Jin Wei; Feng, Shuo; Zhang, Rui Yan; Yang, Chen Die; Lu, Lin; Wang, Xiao Qun

Hepatoprotective drug screening identifies daclatasvir, a promising therapeutic candidate for MASLD by targeting PLIN2

肝保护药物筛选发现达克拉他韦,这是一种通过靶向 PLIN2 治疗 MASLD 的潜在候选药物。

Rui Shu ,Song Tian ,Weiyi Qu ,Jinjie Yang ,Wei Shi ,Xinyan Li ,Toujun Zou ,Changjin Jiang ,Yuxuan Zhang ,Zifeng Yang ,Han Tian ,Hailong Yang ,Jiajun Fu ,Zhi-Gang She ,Hongliang Li ,Xiao-Jing Zhang

Characterization of microvessels in the human forehead dermis using intravascular dual perfusion and immunofluorescence staining.

利用血管内双重灌注和免疫荧光染色对人额部真皮中的微血管进行表征

Rui Shu, Cao Zilong, Wang Yunzhang, Liu Liqiang

Crack Detection in Civil Infrastructure Using Autonomous Robotic Systems: A Synergistic Review of Platforms, Cognition, and Autonomous Action

利用自主机器人系统进行土木基础设施裂缝检测:平台、认知和自主行动的协同综述

Dai, Rong; Wang, Rui; Shu, Chang; Li, Jianming; Wei, Zhe

Dynamics of The Γδtcr Repertoires During The Dedifferentiation Process and Pilot Implications for Immunotherapy of Thyroid Cancer

去分化过程中 Γδtcr 受体库的动态变化及其对甲状腺癌免疫治疗的初步启示

Hao, Qing; Li, Ruicen; Li, Hancong; Rui, Shu; You, Liting; Zhang, Lingyun; Zhao, Yue; Li, Peiheng; Li, Yuanmin; Kong, Xinagyu; Chen, Haining; Zou, Xiuhe; Liu, Feng; Wang, Xiaofei; Zhou, Juan; Zhang, Weihan; Huang, Libing; Shu, Yang; Liu, JiaYe; Sun, Ronghao; Li, Chao; Zhu, Jingqiang; Jiang, Yong; Wei, Tao; Qian, Kun; Bai, Bing; Hu, Yiguo; Peng, Yong; Dai, Lunzhi; Caulin, Carlos; Xu, Heng; Li, Zhihui; Park, Jihwan; Luo, Han; Ying, Binwu

Panda-UV Unlocks Deeper Protein Characterization with Internal Fragments in Ultraviolet Photodissociation Mass Spectrometry

Panda-UV 利用紫外光解离质谱中的内部片段,实现更深入的蛋白质表征

Zhu, Yinlong; Liu, Zheyi; Liu, Jialiang; Zhao, Heng; Feng, Rui; Shu, Kunxian; Wang, Fangjun; Chang, Cheng

The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis

免疫疗法治疗KRAS突变型非小细胞肺癌的疗效:系统评价和荟萃分析

Zhao, Rui; Shu, Yang; Xu, Wei; Jiang, Fengxian; Ran, Pancen; Pan, Liying; Wang, Jingliang; Wang, Weihao; Zhao, Jing; Wang, Yahui; Fu, Guobin

Histone demethylase KDM1A promotes hepatic steatosis and inflammation by increasing chromatin accessibility in NAFLD

组蛋白去甲基化酶KDM1A通过增加染色质可及性促进非酒精性脂肪性肝病(NAFLD)中的肝脂肪变性和炎症。

Zifeng Yang ,Siyao Zhang ,Xiang Liu ,Rui Shu ,Wei Shi ,Weiyi Qu ,Dianyu Liu ,Zhiwei Cai ,Ye Wang ,Xu Cheng ,Yemao Liu ,Xiao-Jing Zhang ,Lan Bai ,Hongliang Li ,Zhi-Gang She